➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Boehringer Ingelheim
Merck
Johnson and Johnson
Medtronic

Last Updated: October 1, 2020

DrugPatentWatch Database Preview

Patent: 10,328,158

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,328,158
Title:Compounds and compositions for immunotherapy
Abstract: The present invention relates to compounds for targeted immunotherapy, as well as compositions comprising the same. Further, the present invention relates to the use of the compounds in the treatment of diseases such as cancer.
Inventor(s): Li; Lixin (Beijing, CN)
Assignee: BIRDIE BIOPHARMACEUTICALS, INC. (Grand Cayman, KY)
Application Number:15/793,820
Patent Claims:see list of patent claims

Details for Patent 10,328,158

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech Inc HERCEPTIN HYLECTA trastuzumab; hyaluronidase-oysk INJECTABLE;SUBCUTANEOUS 761106 001 2019-02-28   Start Trial BIRDIE BIOPHARMACEUTICALS, INC. (Grand Cayman, KY) 2034-01-10 RX search
Genentech Inc RITUXAN HYCELA rituximab; hyaluronidase (human recombinant) SOLUTION;SUBCUTANEOUS 761064 002 2017-06-22   Start Trial BIRDIE BIOPHARMACEUTICALS, INC. (Grand Cayman, KY) 2034-01-10 RX Orphan search
Genentech Inc RITUXAN HYCELA rituximab; hyaluronidase (human recombinant) SOLUTION;SUBCUTANEOUS 761064 001 2017-06-22   Start Trial BIRDIE BIOPHARMACEUTICALS, INC. (Grand Cayman, KY) 2034-01-10 RX Orphan search
Glaxosmithkline Llc BENLYSTA belimumab INJECTABLE;INJECTION 761043 001 2017-07-20   Start Trial BIRDIE BIOPHARMACEUTICALS, INC. (Grand Cayman, KY) 2034-01-10 RX search
Amgen BLINCYTO blinatumomab INJECTABLE;INJECTION 125557 001 2014-12-03   Start Trial BIRDIE BIOPHARMACEUTICALS, INC. (Grand Cayman, KY) 2034-01-10 RX Orphan search
Bristol Myers Squibb OPDIVO nivolumab INJECTABLE;INJECTION 125554 001 2015-11-23   Start Trial BIRDIE BIOPHARMACEUTICALS, INC. (Grand Cayman, KY) 2034-01-10 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Dow
Colorcon
Medtronic
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.